| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/07/2010 | EP2172550A1 C-terminal-a-amidated recombinant enzyme derivative |
| 04/07/2010 | EP2172478A2 Activity-dependent neurotrophic factor III (ADNF III) |
| 04/07/2010 | EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 04/07/2010 | EP2171053A1 Natriuretic polypeptides |
| 04/07/2010 | EP2171039A2 Heterologous and homologous cellulase expression system |
| 04/07/2010 | EP2170106A1 Process for preparing hypoallergenic and non-allergenic peanuts (arachis hypogaea) utilizing an endopeptidase |
| 04/07/2010 | EP1692182B1 Cd20 antibodies with increased fc receptor binding affinity and effector function |
| 04/07/2010 | EP1461431B1 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 04/07/2010 | EP1412513B1 Phosphate limited inducible promoter and a bacillus expression system |
| 04/07/2010 | EP1240331B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/07/2010 | CN1545551B Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 04/07/2010 | CN101692092A Method for quantitatively detecting alpha-synuclein auto-antibodies in human sera |
| 04/07/2010 | CN101692088A Serologic early diagnosis kit for lung cancer |
| 04/07/2010 | CN101691596A Methods of hydrolyzing soyabean protein to produce exorphins |
| 04/07/2010 | CN101691595A Fermentation method for recombinant Pichia pastoris |
| 04/07/2010 | CN101691582A Prokaryotic expression and purification method for listeria monocytogenes hemolysin O |
| 04/07/2010 | CN101691578A Expression system for expressing foreign protein |
| 04/07/2010 | CN101691406A New fusion protein SSI, application and special gene thereof |
| 04/07/2010 | CN101691403A Envelope protein VP28 idiotype monoclonal antibody against shrimp white spot syndrome virus (WSSV) and preparation method thereof |
| 04/07/2010 | CN101691401A Calcium carbonate binding protein, code gene thereof and application thereof |
| 04/07/2010 | CN101691397A Nisin mutant protein, code gene thereof and application thereof |
| 04/07/2010 | CN101691396A Recombination outer membrane protein, coding gene and expression vector of porcine actinobacillus pleuropneumoniae (APP) and preparation method thereof |
| 04/07/2010 | CN101690822A Medicament carrier for targeted medicament delivery on diseases related to macrophage and preparation method thereof |
| 04/07/2010 | CN101095457B Method of producing acid hydrolyzed casein |
| 04/07/2010 | CN101041845B Method for producing chymosin dry casein by using Qula as raw material |
| 04/06/2010 | US7692068 AXMI-010, a delta-endotoxin gene and methods for its use |
| 04/06/2010 | US7692059 Method for generating overexpression of alleles in genes of unknown function |
| 04/06/2010 | US7691992 Nucleic acids encoding the human ALEX1 protein |
| 04/06/2010 | US7691979 Monoclonal antibody named KIS-1N produced by the hybridoma cell line; for development of an agent for the diagnosis and prevention/treatment of diseases (cancer, and so forth) associated with the polypeptide |
| 04/06/2010 | US7691977 Anti-VEGF antibodies |
| 04/06/2010 | US7691815 Methods for blocking TNF-alpha activity in mammals with trimeric soluble TNF receptors |
| 04/06/2010 | US7691632 Kit for detecting the level of cyclin-dependent kinase inhibitor P16 gene expression |
| 04/06/2010 | US7691628 For drug screening for substances useful in treatment of lipid metabolism dysfunctions associated with apolipoprotein C-III; atherosclerosis, hyperlipidaemia, diabetes, obesity, syndrome X, or resistance to insulin and cardiac and coronary diseases |
| 04/06/2010 | US7691619 for production of a rare sugar using genetic engineering; catalyzes an isomerization reaction from L-rhamnose to L-rhamnulose and also an isomerization reaction from L-rhamnulose to L-rhamnose; production of D-allose |
| 04/06/2010 | US7691617 Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions |
| 04/06/2010 | US7691616 Cytochrome P450 oxygenases |
| 04/06/2010 | US7691611 Production of recombinant IL-18 binding protein |
| 04/06/2010 | US7691610 Vectors and host cells for Zven biodrug production; agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis |
| 04/06/2010 | US7691608 Nucleic acids encoding recombinant protein A |
| 04/06/2010 | US7691606 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases |
| 04/06/2010 | US7691605 Selection of cells expressing heteromeric polypeptides |
| 04/06/2010 | US7691603 Intracellular formation of peptide conjugates |
| 04/06/2010 | US7691589 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens |
| 04/06/2010 | US7691588 Ligand having agonistic activity to mutated receptor |
| 04/06/2010 | US7691568 Antibody composition-containing medicament |
| 04/06/2010 | US7691566 Compositions and methods for treatment of cancer |
| 04/06/2010 | US7691395 BASB119 polypeptide and polynucleotide from Moraxella catarrhalis |
| 04/06/2010 | US7691390 polypeptide and isolated nucleic acid encoding the polypeptide for SARS CoV protein 3a, which can serve as a target for elucidating the mechanisms of SARS and developing vaccines and therapeutics |
| 04/06/2010 | US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 04/06/2010 | US7691380 Coagulating the vascular systems of cancer cells through site specific delivery of coagulant antibodies causing regression of the cells |
| 04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
| 04/06/2010 | US7691376 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes |
| 04/06/2010 | US7691373 Antibody that binds to mammalian Dendritic Cell Membrane Protein (DCMP) genes; immunostimulants |
| 04/06/2010 | CA2445035C Mutants of green fluorescent protein |
| 04/06/2010 | CA2280930C Protein markers for lung cancer and use thereof |
| 04/06/2010 | CA2253243C Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 04/06/2010 | CA2252466C Hepatitis b monoclonal antibodies |
| 04/06/2010 | CA2188919C Monoclonal antibodies which promote central nervous system remyelination |
| 04/06/2010 | CA2181334C Bacterial strains of genus bacillus closely phenotypically related to genus lactobacillus, culture method and use |
| 04/06/2010 | CA1341602C Promotors of filamentous fungi and use thereof |
| 04/01/2010 | WO2010037062A1 Non-natural amino acid replication-dependent microorganisms and vaccines |
| 04/01/2010 | WO2010036979A2 Novel vectors for production of interferon |
| 04/01/2010 | WO2010036964A2 Modified animal erythropoietin polypeptides and their uses |
| 04/01/2010 | WO2010035769A1 Improved antibody molecule |
| 04/01/2010 | WO2010034708A1 A polynucleotide expression cassette |
| 04/01/2010 | WO2010034243A1 Novel gene cluster |
| 04/01/2010 | WO2010034103A1 Method for polyclonal immunoglobulin g production by human b cells |
| 04/01/2010 | WO2010011957A3 Enzymatic hydrolysis of cellulosic biomass through enhanced removal of oligomers |
| 04/01/2010 | WO2010011679A3 Improved protein production in a host |
| 04/01/2010 | WO2009149199A3 Composition, method and kit for preparing plasmin |
| 04/01/2010 | WO2009094751A8 An anti-cancer cytotoxic monoclonal antibody |
| 04/01/2010 | WO2008157776A9 Modified diphtheria toxins |
| 04/01/2010 | US20100083403 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 04/01/2010 | US20100083392 Hafnia phytase variants |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081793 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 04/01/2010 | US20100081789 Novel Vectors for Production of Interferon |
| 04/01/2010 | US20100081709 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses |
| 04/01/2010 | US20100081703 Tri-demethylation-capable protein complex, method of its preparation and its use |
| 04/01/2010 | US20100081615 Continuation - site directed modification of fviii |
| 04/01/2010 | US20100081612 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/01/2010 | US20100081192 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 04/01/2010 | US20100081172 N-Glycans and Uses Thereof |
| 04/01/2010 | US20100081171 Method for lyophilizing competent cells |
| 04/01/2010 | US20100081170 in high yields, with native conformation, and/or in soluble form include solubilizing in non-ionic or zwitterionic detergents; comprises polynucleotide encoding a multiple-membrane-spanning CD20 polypeptide |
| 04/01/2010 | US20100081169 Production of a lipid acyltransferase from transformed bacillus licheniformis cells |
| 04/01/2010 | US20100081168 Use of Acid Stable Protease in Animal Feed |
| 04/01/2010 | US20100080815 MN Gene and Protein |
| 04/01/2010 | US20100080812 Antibodies against human IL17 and uses thereof |
| 04/01/2010 | US20100080806 Anti-human trail receptor dr5 monoclonal antibody (ad5-10), method thereof and use of the same |
| 04/01/2010 | US20100080804 Methods of treating inflammatory disorders of the lungs |
| 04/01/2010 | US20100080801 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases |
| 04/01/2010 | US20100080796 Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
| 04/01/2010 | US20100080794 Mutant polypeptide having effector function |
| 04/01/2010 | US20100080793 DcR3 polypeptide, A TNFR homolog |
| 04/01/2010 | US20100080774 Lactococcus promoters and uses thereof |
| 04/01/2010 | CA2763039A1 Improved antibody molecules |
| 04/01/2010 | CA2738248A1 Methods and compositions for increasing toxin production |
| 04/01/2010 | CA2738033A1 Non-natural amino acid replication-dependent microorganisms and vaccines |
| 03/31/2010 | EP2169076A2 Enzymes having alpha amylase activity and methods of use thereof |